RedShiftBio has developed a proprietary infrared spectroscopy platform combining our Microfluidic Modulation Spectroscopy (MMS) and expertise in high-powered quantum cascade lasers.  This technology provides ultra-sensitive and ultra-precise measurements of molecular structure.  Changes in protein structure and RNA structure and base pairing affect critical quality attributes governing the safety, efficacy, specificity, and stability of biomolecules, therapeutics, and their raw materials.  Our fully automated Aurora TX system utilizes a 96-well plate, 50ul of sample, and provides both structure as well as stability, measured with thermal ramping, for your RNA, DNA, proteins, and peptides. Aurora TX is complemented by a full analytics software suite which allows for rapid and straightforward data analysis and report generation, with minimal training or expertise required.  Our instrumentation and software solutions are backed by a global network of sales, applications, service, and support teams to address all market needs.

RedShiftBio is a Massachusetts-based biotech company, led by an experienced management team with a proven track record of success in both selling and supporting instrumentation as well as commercializing disruptive technologies.  RedShiftBio is here to support your research, development, and manufacturing needs.  Our instruments can be found in the majority of the leading biopharmaceutical companies and CDMOs in addition to government and academic research centers around the world.